Clinical care pathway program versus open-access system: a study on appropriateness, quality, and efficiency in the delivery of colonoscopy in the colorectal cancer

被引:0
|
作者
Giovanna Del Vecchio Blanco
Rami Dwairi
Mario Giannelli
Giampiero Palmieri
Vincenzo Formica
Ilaria Portarena
Enrico Grasso
Laura Di Iorio
Michela Benassi
Emilia Anna Giudice
Antonella Nardecchia
Piero Rossi
Mario Roselli
Giuseppe Sica
Giovanni Monteleone
Omero Alessandro Paoluzi
机构
[1] University of Rome “Tor Vergata”,Department of Systems Medicine, Gastroenterology Unit
[2] University of Mutah,Department of Internal Medicine
[3] University “Tor Vergata”,Department of Biomedicine and Prevention, Anatomic Pathology Unit
[4] University Tor Vergata,Department of Oncohematology, Oncology Unit
[5] University “Tor Vergata”,Department of Diagnostic Imaging, Interventional Radiology and Radiotherapy
[6] University Tor Vergata,Department of Surgery
来源
Internal and Emergency Medicine | 2021年 / 16卷
关键词
Clinical care pathway; Colonoscopy; Colorectal cancer; Open-access colonoscopy;
D O I
暂无
中图分类号
学科分类号
摘要
Open-access colonoscopy (OAC), whereby the colonoscopy is performed without a prior office visit with a gastroenterologist, is affected by inappropriateness which leads to overprescription and reduced availability of the procedure in case of alarming symptoms. The clinical care pathway (CCP) is a healthcare management tool promoted by national health systems to organize work-up of various morbidities. Recently, we started a CCP dedicated to colorectal cancer (CRC), including a colonoscopy session for CRC diagnosis and prevention. We aimed to evaluate the appropriateness, the quality, and the efficiency in the delivery of colonoscopy with the open-access system and a CCP program in the CRC. Quality indicators for colonoscopy in subjects in the CCP were compared to referrals by general practitioners (OAC) or by non-gastroenterologist physicians (non-gastroenterologist physician colonoscopy, NGPC). Attendance rate to colonoscopy was greater in the CCP group and NGPC group than in the OAC group (99%, 99%, and 86%, respectively). Waiting time in the CCP group was shorter than in the OAC group (3.88 ± 2.27 vs. 32 ± 22.31 weeks, respectively). Appropriateness of colonoscopy prescription was better in the CCP group than in the OAC group (92 vs. 50%, respectively). OAC is affected by the lack of timeliness and low appropriateness of prescription. A CCP reduces the number of inappropriate colonoscopies, especially for post-polypectomy surveillance, and improves the delivery of colonoscopy in patients requiring a fast-track examination. The high rate of inappropriate OAC suggests that this modality of healthcare should be widely reviewed.
引用
收藏
页码:1197 / 1206
页数:9
相关论文
共 50 条
  • [41] Quality control by photograph for evaluation of open (OP) and laparoscopic (LAP) colectomy with 1)3 resection for stage Hint colorectal cancer: Japan Clinical Oncology Group study JCOG 0404.
    Nakajima, Kentaro
    Inomata, Masafumi
    Akagi, Tomonori
    Etoh, Tsuyoshi
    Katayama, Hiroshi
    Ito, Masaaki
    Fujil, Sholchi
    Salto, Shuji
    Konishi, Fumlo
    Saida, Yoshihisa
    Hasegawa, Hirotoshi
    Yamaguchi, Takashi
    Fukunaga, Yosuke
    Sugihara, Kenichi
    Watanabe, Masahiko
    Yamamoto, Seilchiro
    Shimoda, Yasuhiro
    Moriya, Yoshihiro
    Kitano, Seigo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Transitional impact of short and long-term outcomes of a randomized controlled trial to evaluate laparoscopic versus open surgery for colorectal cancer from Japan Clinical Oncology Group Study JCOG0404
    Fujii, S.
    Inomata, M.
    Akagi, T.
    Katayama, H.
    Mizusawa, J.
    Saito, S.
    Saida, Y.
    Munakata, Y.
    Sato, T.
    Bandou, H.
    Sekimoto, M.
    Yamamoto, H.
    Shimada, Y.
    Kitano, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S139 - S139
  • [43] A phase 2, randomized, open-label study of onvansertib in combination with standard-of-care (SoC) versus SoC alone for first-line treatment of RAS-mutant metastatic colorectal cancer (mCRC)
    Lenz, Heinz-Josef
    Kuritzky, Benjamin
    Thummala, Anu
    Kendall, Stephan
    Patel, Ravindranath
    Chandana, Sreenivasa R.
    Bent, Alisha H.
    Sherman, Nancy
    Subramanian, Ramanand Arun
    Kabbinavar, Fairooz
    Hecht, Joel Randolph
    CANCER RESEARCH, 2024, 84 (07)
  • [44] Transitional impact of short- and long-term outcomes of a randomized controlled trial to evaluate laparoscopic versus open surgery for colorectal cancer from Japan Clinical Oncology Group Study JCOG0404
    Fujii, Shoichi
    Akagi, Tomonori
    Inomata, Masafumi
    Katayama, Hiroshi
    Mizusawa, Junki
    Ota, Mitsuyoshi
    Saito, Shuji
    Kinugasa, Yusuke
    Yamaguchi, Shigeki
    Sato, Takeo
    Kitano, Seigo
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2019, 3 (03): : 301 - 309
  • [45] Evaluation of health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC): A prospective, multicenter, open-label, double-arm trial of trifluridine/tipiracil (FTD/TPI) versus best supportive care (BSC).
    Karthaus, Meinolf
    Welslau, Manfred
    Riera-Knorrenschild, Jorge
    Kretzschmar, Albrecht
    Vehling-Kaiser, Ursula
    Mahlberg, Rolf
    Pelz, Henning
    Lindig, Udo
    von Weikersthal, Ludwig Fischer
    Heinemann, Volker
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [46] Validation of cost-effectiveness of trifluridine/tipiracil versus best supportive care and regorafenib for previously treated metastatic colorectal cancer in the UK using phase IIIb PRECONNECT early access clinical trial data in the real world setting.
    Sabater, Javier
    Ralph, Lewis
    Batteson, Rachael
    McCarthy, Grant
    Wex, Jaro
    Vera, Shanti Ricardo Moreno
    Becquart, Martin
    Mounedji, Nadjat
    Taieb, Julien
    Peeters, Marc
    Falcone, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [47] Short-term clinical outcomes from a randomized controlled trial to evaluate laparoscopic versus open complete mesocolic excision for stage II,III colorectal cancer (CRC): Japan Clinical Oncology Group study JCOG0404 (NCT00147134).
    Nishizawa, Yusuke
    Saito, Norio
    Inomata, Masafumi
    Etoh, Tsuyoshi
    Kitano, Seigo
    Katayama, Hiroshi
    Mizusawa, Junki
    Yamamoto, Seiichiro
    Kinugasa, Yusuke
    Fujii, Shoichi
    Konishi, Fumio
    Saida, Yoshihisa
    Shimada, Yasuhiro
    Moriya, Yoshihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] A randomized controlled trial to evaluate laparoscopic versus open complete mesocolic excision (CME) for stage II, III colorectal cancer (CRC): First efficacy results from Japan Clinical Oncology Group Study JCOG0404.
    Inomata, Masafumi
    Katayama, Hiroshi
    Mizusawa, Junki
    Watanabe, Masahiko
    Sugihara, Kenichi
    Konishi, Fumio
    Yamamoto, Seiichiro
    Saito, Shuji
    Fujii, Shoichi
    Saida, Yoshihisa
    Hasegawa, Hirotoshi
    Etoh, Tsuyoshi
    Moriya, Yoshihiro
    Kitano, Seigo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [49] Effects of closed- versus open-system intensive care units on mortality rates in patients with cancer requiring emergent surgical intervention for acute abdominal complications: a single-center retrospective study in Korea
    Lee, Jae Hoon
    Kim, Jee Hee
    You, Ki Ho
    Han, Won Ho
    ACUTE AND CRITICAL CARE, 2024, 39 (04) : 554 - 564
  • [50] A randomized controlled trial to evaluate laparoscopic versus open with Japanese D3 dissection for stage II,III colorectal cancer (CRC): First efficacy results from Japan Clinical Oncology Group Study JCOG0404
    Akagi, Tomonori
    Inomata, Masafumi
    Katayama, Hiroshi
    Mizusawa, Junki
    Yamaguchi, Takashi
    Masaki, Tadahiko
    Fukunaga, Yosuke
    Murata, Kohei
    Okajima, Masazumi
    Munakata, Yasuhiro
    Sato, Takeo
    Bandou, HIroyuki
    Yasui, Masayoshi
    Sekimoto, Mitsugu
    Watanabe, Masahiko
    Sugihara, Kenichi
    Konishi, Fumio
    Etoh, Tsuyoshi
    Shimada, Yasuhiro
    Kitano, Seigo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)